Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 5.07M | $37.0M | 13.03% | -- | 2026-06-30 |
| 5AM Venture Management, LLC | 4.06M | $29.0M | 10.42% | -- | 2026-06-30 |
| BlackRock, Inc. | 2.58M | $19.0M | 6.63% | +224.5K | 2026-06-30 |
| Merck & Co., Inc. | 1.74M | $12.0M | 4.47% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 1.27M | $9.0M | 3.26% | +13.6K | 2026-06-30 |
| Mpm Bioimpact LLC | 1.25M | $9.0M | 3.22% | -- | 2026-06-30 |
| TCG Crossover Management, LLC | 1.06M | $7.0M | 2.72% | -1.23M | 2026-06-30 |
| Wellington Management Group LLP | 954.4K | $7.0M | 2.45% | -80.4K | 2026-06-30 |
| Millennium Management LLC | 764.0K | $5.0M | 1.96% | +244.6K | 2026-06-30 |
| StepStone Group LP | 761.3K | $5.0M | 1.96% | -- | 2026-06-30 |
